The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDesign Group Regulatory News (IGR)

Share Price Information for Design Group (IGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 121.50
Bid: 118.00
Ask: 125.00
Change: 0.00 (0.00%)
Spread: 7.00 (5.932%)
Open: 121.50
High: 121.50
Low: 121.50
Prev. Close: 121.50
IGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

28 Mar 2017 10:34

RNS Number : 7444A
IG Design Group PLC
28 March 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

IG DESIGN GROUP PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other:

3. Full name of person(s) subject to thenotification obligation: iii

HARGREAVE HALE LIMITED

4. Full name of shareholder(s)  (if different from 3.):iv

DISCRETIONARY CLIENTS

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

24 MARCH 2017

6. Date on which issuer notified:

27 MARCH 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Indirect

Direct xi

Indirect xii

Direct

Indirect

GB0004526900

3,057,700

3,057,700

3,182,700

3,182,700

5.0808%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,182,700

5.0808%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

3,125,000 of these shares are held in a unit trust operated by Marlborough Fund Managers Ltd, for whom Hargreave Hale Ltd manages the portfolio of investments on a discretionary basis. The remaining shares are held on behalf of other discretionary clients.

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

David Clueit

Hargreave Hale Ltd

15. Contact telephone number:

01253 754739

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLJPMLTMBJTMBR
Date   Source Headline
16th Feb 20244:08 pmRNSHolding(s) in Company
9th Feb 20244:30 pmRNSCompletion of EBT Share Purchase Programme
9th Feb 202411:58 amRNSEBT Share Purchase
5th Feb 20247:00 amRNSEBT Share Purchase
29th Jan 20247:00 amRNSEBT Share Purchase
22nd Jan 20245:00 pmRNSHolding(s) in Company
22nd Jan 20247:00 amRNSEBT Share Purchase
16th Jan 20245:34 pmRNSHolding(s) in Company
15th Jan 202411:48 amRNSEBT Share Purchase
3rd Jan 20247:00 amRNSHolding(s) in Company
3rd Jan 20247:00 amRNSBlock Listing Return
2nd Jan 20247:00 amRNSEBT Share Purchase
29th Dec 20231:00 pmRNSHolding(s) in Company
27th Dec 202311:37 amRNSEBT Share Purchase
13th Dec 20235:04 pmRNSIntended Purchase of Shares by EBT
7th Dec 20237:00 amRNSHolding(s) in Company
6th Dec 20234:32 pmRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSInterim Results
25th Oct 20237:00 amRNSTrading Update
14th Sep 20232:47 pmRNSResult of AGM
10th Aug 20237:00 amRNSLong Term Incentive Plan Awards
18th Jul 20237:00 amRNSPosting of Annual Report and Notice of AGM
13th Jul 20233:33 pmRNSDirector/PDMR Shareholding
3rd Jul 20237:00 amRNSBlock listing Return
20th Jun 20237:00 amRNSFull Year Results
14th Jun 20231:56 pmRNSBlock Listing Application
5th Jun 20232:16 pmRNSNew Debt Facilities
19th May 20237:00 amRNSNotice of Investor Presentation
5th May 20237:00 amRNSAppointment of Group Chief Financial Officer
4th May 20237:00 amRNSHolding(s) in Company
20th Apr 20237:00 amRNSPost Close Trading Update
24th Mar 20237:00 amRNSBoard Change
9th Mar 20236:16 pmRNSHolding(s) in Company
13th Jan 20234:40 pmRNSSecond Price Monitoring Extn
13th Jan 20234:35 pmRNSPrice Monitoring Extension
10th Jan 20234:40 pmRNSSecond Price Monitoring Extn
10th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20238:23 amRNSHolding(s) in Company
5th Jan 20233:26 pmRNSHolding(s) in Company
28th Dec 20227:00 amRNSHolding(s) in Company
15th Dec 20227:00 amRNSBlock Listing Return
13th Dec 20224:06 pmRNSHolding(s) in Company
2nd Dec 20227:00 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSInterim Results
16th Nov 202210:50 amRNSHolding(s) in Company
3rd Nov 20227:00 amRNSAppointment of Chief Executive Officer
20th Oct 20227:00 amRNSTrading Update
6th Oct 202210:30 amRNSHolding(s) in Company
30th Sep 20229:36 amRNSEBT Share Purchase
29th Sep 20227:00 amRNSIntended Purchase of Shares by EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.